OCC 8.11% 40.0¢ orthocell limited

Ann: Orthocell Receives First US CelGro Product Approval, page-149

  1. 369 Posts.
    lightbulb Created with Sketch. 144
    OCC’s comms and marketing is really substandard. Basic SEO/SEM setup would be a huge help. And as discussed not having ‘FDA’ in the title of an approval release is piss poor. Makes me concerned about the company. I believe in the products but struggling to keep the faith in their ability to commercialise and promote them properly.
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.